Presse Medicale

Papers
(The median citation count of Presse Medicale is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Lung involvement in ANCA-associated vasculitis34
Update on treatment in multiple sclerosis31
Interstitial lung diseases in children25
Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy24
Updates for the treatment of EGPA22
Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients21
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance21
Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases20
The enigma of the 1889 Russian flu pandemic: A coronavirus?19
Management of cutaneous vasculitis18
Chemical hazard of tattoo colorants16
Life and death of smallpox16
Scleroderma renal crisis15
Evolution and treatment of idiopathic pulmonary fibrosis15
Diabetes insipidus14
Digital Ulcers in Systemic Sclerosis13
Pituitary Surgery12
The Spanish flu12
Pathophysiology of systemic sclerosis12
A brief history of malaria12
Cutaneous non-allergic complications in tattoos: An overview of the literature11
Tattoo allergy. Can we identify the allergen?11
Renal involvement in IgG4-related disease11
Autoimmunity in lipodystrophy syndromes10
Adult interstitial lung diseases and their epidemiology10
IgG4 hypophysitis: Diagnosis and management10
Autologous stem cell transplantation in scleroderma10
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis9
Thyroid functional and molecular imaging9
Lung transplantation for idiopathic pulmonary fibrosis9
Treatment of systemic sclerosis9
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management8
Covid-19, an unfinished story8
Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults8
Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification8
Cushing's disease8
Functional imaging in thyroid cancer patients with metastases and therapeutic implications8
Hypophysitis: A comprehensive overview7
Pathophysiology of IgG4-related disease: A T follicular helper cells disease?7
Pituitary incidentaloma7
Prolactinomas7
Treatment of systemic necrotizing vasculitides: The 40-year experience of the French Vasculitis Study Group7
Rehabilitation in multiple sclerosis in 20217
Primary ciliary dyskinesia7
Pulmonary arterial hypertension in systemic sclerosis6
Clinical pharmacology of antidiabetic drugs: What can be expected of their use?6
Diagnostic approach of fibrosing interstitial lung diseases of unknown origin6
Cardiac functional imaging6
Cholera in Haiti6
From islet of Langerhans transplantation to the bioartificial pancreas6
Familial partial lipodystrophy syndromes6
How to advise a patient who wants a tattoo?6
The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas6
What do the IgG4-related disease (IgG4-RD) classification criteria tell us about the nature of IgG4-RD?6
Multiple symmetric and multiple familial lipomatosis5
Pathological characteristics and diagnosis of IgG4-related disease5
Current legislation on tattooing in France5
Recent advances on cutaneous lymphoma epidemiology5
Tattoo and epidural analgesia: Rise and fall of a myth5
Pancreatic and biliary tract involvement in IgG4-related disease5
Craniopharyngiomas5
Update on brain MRI for the diagnosis and follow-up of MS patients5
Yellow fever: A brief history of a tropical Virosis5
The current and future contribution of neuroimaging to the understanding of disorders of consciousness5
Metreleptin treatment of non-HIV lipodystrophy syndromes5
Genetics of lipodystrophy syndromes5
Pediatric onset multiple sclerosis: Future challenge for early diagnosis and treatment5
New biotherapies for the treatment of cutaneous T-cell lymphomas4
Clinically non-functioning pituitary adenomas4
Systemic diseases and infections, anecdotal complications and oddities associated with tattooing4
Complications of lipodystrophy syndromes3
History of the plague of 1720-1722, in Marseille3
Machine learning in lung transplantation: Where are we?3
Multiple sclerosis diagnostic criteria: From poser to the 2017 revised McDonald criteria3
Functional Imaging for Neurodegenerative Diseases3
Adrenal functional imaging3
Idiopathic pulmonary fibrosis3
Mesocircuit mechanisms in the diagnosis and treatment of disorders of consciousness3
Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management3
Molecular Imaging in neuroendocrine neoplasias2
Bronchiectasis2
French Vasculitis Study Group recommendations for the management of COVID-19 vaccination and prophylaxis in patients with systemic vasculitis2
Differential diagnosis of multiple sclerosis2
HIV / AIDS as a model for emerging infectious disease: Origin, dating and circumstances of an emblematic epidemiological success2
Updates in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis: At a crossroad2
Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments2
Cystic fibrosis2
Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact2
End-stage heart failure: The future of heart transplant and artificial heart2
History of measles2
Unraveling complexity of antibody-mediated rejections, the mandatory way towards an accurate diagnosis and a personalized treatment2
Generalized lipoatrophy syndromes2
How to improve results after DCD (donation after circulation death)1
Severity of kidney involvement as predictor of death, severe heart failure and renal events in patients with type 2 diabetes: Data from a prospective cohort1
Functional imaging for evaluation of cancers and biologically conformal radiotherapy: Past-history and present-day perspectives.1
International variability in the diagnosis and management of disorders of consciousness1
Letter on the article “Long-COVID: Cognitive deficits (brain fog) and brain lesions in non hospitalized patients”1
Chronic heart failure with reduced EF: A decade of major pharmacological innovations1
Renal disease in patients with type 2 diabetes: Magnitude of the problem, risk factors and preventive strategies1
Pulmonary arterial hypertension1
The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease1
Electrical therapies in heart failure: Evolving technologies and indications1
Sickle cell disease and pregnancy1
COVID-19 and kidney transplantation1
Fecal microbiota transplantation: History, procedure and regulatory considerations1
Diagnostic criteria and etiopathogenesis of type 2 diabetes and its complications: Lessons from the Pima Indians1
Benefits of intensified reductions in blood glucose and in blood pressure for patients with type 2 diabetes1
Vascular pathophysiology of sickle cell disease1
Lymphangioleiomyomatosis1
Towards etiological treatments in cardiomyopathies1
New developments in skin-directed treatments of cutaneous T-cell lymphoma1
New insights in acute heart failure1
New concepts on immunology of Multiple Sclerosis1
Heart failure with preserved ejection fraction: New challenges and new hopes1
Functional imaging for hyperparathyroidism1
New immunosuppressive agents in transplantation1
0.085928916931152